Healthcare Innovation August 15, 2023
OneDukeGen plans to recruit more than 100,000 consented Duke patients to participate in the research
The Duke University Health System and School of Medicine have launched a precision medicine study called OneDukeGen that will integrate comprehensive genomic data and clinical information to foster a deeper understanding of hereditary disease susceptibilities.
Led by Principal Investigator Svati Shah, M.D., M.H.S., a cardiologist and associate dean of genomics, the study aims to recruit more than 100,000 consented Duke patients to participate in the research.
The purpose of the OneDukeGen Genomic Sequencing Study and Biorepository (OneDukeGen) is to collect biological samples, and use the samples to analyze DNA, and other material (like RNA) for use in research related to a variety of diseases and...
Today's Sponsors
Today's Sponsor